<?xml version="1.0" encoding="UTF-8" ?>
<rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:wikidot="http://www.wikidot.com/rss-namespace">

	<channel>
		<title>Paradigms Shift Bladder Cancer</title>
		<link>https://isocentre.wikidot.com/forum/t-350972/paradigms-shift-bladder-cancer</link>
		<description>Posts in the discussion thread &quot;Paradigms Shift Bladder Cancer&quot; - International Phase III Trial Assessing Neoadjuvant Cisplatin, Methotrexate, and Vinblastine Chemotherapy for Muscle-Invasive Bladder Cancer: Long-Term Results of the BA06 30894 Trial</description>
				<copyright></copyright>
		<lastBuildDate>Thu, 12 Nov 2026 03:44:30 +0000</lastBuildDate>
		
					<item>
				<guid>http://isocentre.wikidot.com/forum/t-350972#post-1140518</guid>
				<title>Re: Paradigms Shift Bladder Cancer</title>
				<link>https://isocentre.wikidot.com/forum/t-350972/paradigms-shift-bladder-cancer#post-1140518</link>
				<description></description>
				<pubDate>Sun, 01 May 2011 03:48:46 +0000</pubDate>
				<wikidot:authorName>Nikhilesh Patil</wikidot:authorName>				<wikidot:authorUserId>416151</wikidot:authorUserId>				<content:encoded>
					<![CDATA[
						 <p>I don't have any experience with chemo, I found the paper interesting. Also bladder cancers are difficult to treat. I will have to check our med onc what chemo they prefer..</p> 
				 	]]>
				</content:encoded>							</item>
					<item>
				<guid>http://isocentre.wikidot.com/forum/t-350972#post-1138315</guid>
				<title>Re: Paradigms Shift Bladder Cancer</title>
				<link>https://isocentre.wikidot.com/forum/t-350972/paradigms-shift-bladder-cancer#post-1138315</link>
				<description></description>
				<pubDate>Thu, 28 Apr 2011 07:54:40 +0000</pubDate>
				<wikidot:authorName>Santam Chakraborty </wikidot:authorName>				<wikidot:authorUserId>416676</wikidot:authorUserId>				<content:encoded>
					<![CDATA[
						 <p>Could not see the full text so perhaps making a naive comment here.. but I wonder what the role of neoadjuvant chemotherapy in the setting of concurrent chemoradiation protocols in bladder cancer? Anyone with direct experience?</p> 
				 	]]>
				</content:encoded>							</item>
					<item>
				<guid>http://isocentre.wikidot.com/forum/t-350972#post-1138150</guid>
				<title>Re: Paradigms Shift Bladder Cancer</title>
				<link>https://isocentre.wikidot.com/forum/t-350972/paradigms-shift-bladder-cancer#post-1138150</link>
				<description></description>
				<pubDate>Thu, 28 Apr 2011 02:18:48 +0000</pubDate>
				<wikidot:authorName>Rohit Malde</wikidot:authorName>				<wikidot:authorUserId>418807</wikidot:authorUserId>				<content:encoded>
					<![CDATA[
						 <p>Neodjuvant chemo in Advanced bladder cancer has been practised over 7-8 years now since the publication by the ABC Meta-analysis Colloboration, 2003 which as far i can remember is based on some 3000 pts, including some 10-11 RCTs, which concluded with a 5% Absolute benefit in OS increasing 5y OS from 45% to 50% in favour of neoadjuvant chemotherapy.</p> <p>There has been some recent update which estimates this benefit at 6.4% at 7 year Follow up (published in 2010 or 2011)</p> <p>The Std Chemo regimen internationally practised is usually Cisplatin 75&#160;mg/m2 D1, Gemcitabine 1&#160;g / m2 D1, 8 , 15 [ 28 day cycle ]</p> <p>The only major problem is this should be offered to patients who are fit and well with KPS &gt;70%, with adequate renal function.</p> <p>MVAC and CMV chemo are now considered out of date as there is clear evidence of increased toxicity compared with Cis / Gem (at least in the mets setting&#8230; direct randomised data).<br /> But for discussion purpose, all these regimens are equivalent wrt local control and overall survival.</p> 
				 	]]>
				</content:encoded>							</item>
					<item>
				<guid>http://isocentre.wikidot.com/forum/t-350972#post-1137642</guid>
				<title>Paradigms Shift Bladder Cancer</title>
				<link>https://isocentre.wikidot.com/forum/t-350972/paradigms-shift-bladder-cancer#post-1137642</link>
				<description></description>
				<pubDate>Wed, 27 Apr 2011 14:36:50 +0000</pubDate>
				<wikidot:authorName>Nikhilesh Patil</wikidot:authorName>				<wikidot:authorUserId>416151</wikidot:authorUserId>				<content:encoded>
					<![CDATA[
						 <p>Dear all,<br /> You cannot miss this paper &quot;International Phase III Trial Assessing Neoadjuvant Cisplatin, Methotrexate, and Vinblastine Chemotherapy for Muscle-Invasive Bladder Cancer: Long-Term Results of the BA06&#160;30894 Trial&quot;</p> <p><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=International%20Phase%20III%20Trial%20Assessing%20Neoadjuvant%20Cisplatin%2C%20Methotrexate%2C%20and%20Vinblastine%20Chemotherapy%20for%20Muscle-Invasive%20Bladder%20Cancer%3A%20Long-Term%20Results%20of%20the%20BA06%2030894%20Trial">http://www.ncbi.nlm.nih.gov/pubmed?term=International%20Phase%20III%20Trial%20Assessing%20Neoadjuvant%20Cisplatin%2C%20Methotrexate%2C%20and%20Vinblastine%20Chemotherapy%20for%20Muscle-Invasive%20Bladder%20Cancer%3A%20Long-Term%20Results%20of%20the%20BA06%2030894%20Trial</a></p> 
				 	]]>
				</content:encoded>							</item>
				</channel>
</rss>